loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for pharmaceutical excipient solutions? Find poly dl lactide co glycolide manufacturers & suppliers on PharmaCompass.

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    View Presentation

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Poly DL Lactide co Glycolide

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Seqens

    02 3Nanjing Well Pharmaceutical

    03 3Nomisma Healthcare

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Seqens

    France
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Expansorb® PLGA / PEG

    Application : Parenteral

    Excipient Details : Expansorb® PLGA? / PEG copolymers are used as functional excipients in single dose injections for controlled and slow drug release (weeks to months).

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : EXPANSORB® PLGA / PEG

    Applications : Expansorb® PLGA? / PEG copolymers are used as functional excipients in single dose injections for controlled and slow drug release (weeks to months).

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Grade : Parenteral

    arrow
    Expansorb® PLGA / PEG

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Polylactide-co-glycolide (5...

    Application : Parenteral

    Excipient Details : Poly(lactide-co-glycolide) (50:50) is a biodegradable carrier used in parenteral dosage forms. It is also used to develop controlled release products.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (50:50); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 35-45 mL/g; Storage conditions: -20 ~ 8 ° C

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : POLYLACTIDE-CO-GLYCOLIDE (50:50)

    Applications : Poly(lactide-co-glycolide) (50:50) is a biodegradable carrier used in parenteral dosage forms. It is also used to develop controlled release products.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (50:50); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 35-45 mL/g; Storage conditions: -20 ~ 8 ° C

    Grade : Parenteral

    arrow
    Nanjing Well Polylactide-co-glycolide (50:50)

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Seqens

    France
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Expansorb® PLGA

    Application : Parenteral

    Excipient Details : Expansorb® PLGA copolymers are used as functional excipients for slow and controlled drug release (weeks to months) with a single injection.

    Pharmacopoeia Ref : NA

    Technical Specs : Classic and ultrapure LMP

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : EXPANSORB® PLGA

    Applications : Expansorb® PLGA copolymers are used as functional excipients for slow and controlled drug release (weeks to months) with a single injection.

    Pharmacopoeia Ref : NA

    Technical Specs : Classic and ultrapure LMP

    Grade : Parenteral

    arrow
    Expansorb® PLGA

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    Nanjing Well Pharmaceutical

    China
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Polylactide-co-glycolide (7...

    Application : Parenteral

    Excipient Details : Poly (lactide-co-glycolide) (75:25) is used as a carrier material for sustained-release formulations including microspheres, nanocapsules & gels.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (75:25); Intrinsic Viscosity: 20-30 mL/g, 30-40 mL/g, 40-50 mL/g

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : POLYLACTIDE-CO-GLYCOLIDE (75:25)

    Applications : Poly (lactide-co-glycolide) (75:25) is used as a carrier material for sustained-release formulations including microspheres, nanocapsules & gels.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (75:25); Intrinsic Viscosity: 20-30 mL/g, 30-40 mL/g, 40-50 mL/g

    Grade : Parenteral

    arrow
    Nanjing Well Polylactide-co-glycolide (75:25)

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Seqens

    France
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Expansorb® PLGA 55:45-Glu

    Application : Parenteral

    Excipient Details : Expansorb® PLGA 55:45-Glu is lactic acid & glycolic acid copolymer used as functional excipients in injectables for slow and controlled drug release.

    Pharmacopoeia Ref : NA

    Technical Specs : Classic and ultrapure LMP

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : EXPANSORB® PLGA 55:45-GLU

    Applications : Expansorb® PLGA 55:45-Glu is lactic acid & glycolic acid copolymer used as functional excipients in injectables for slow and controlled drug release.

    Pharmacopoeia Ref : NA

    Technical Specs : Classic and ultrapure LMP

    Grade : Parenteral

    arrow
    Expansorb® PLGA 55:45-Glu

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Nanjing Well Pharmaceutical

    China
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Polylactide-co-glycolide (8...

    Application : Parenteral

    Excipient Details : Poly (lactide-co-glycolide) (85:15) is a biodegradable carrier used in parenteral controlled release dosage forms such as microspheres & nanocapsules.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (85:15); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 35-45 mL/g, Storage conditions: -20 ~ 8 ° C

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : PLGA Polymers

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : POLYLACTIDE-CO-GLYCOLIDE (85:15)

    Applications : Poly (lactide-co-glycolide) (85:15) is a biodegradable carrier used in parenteral controlled release dosage forms such as microspheres & nanocapsules.

    Pharmacopoeia Ref : ChP/USP

    Technical Specs : Polylactide-co-glycolide (85:15); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 35-45 mL/g, Storage conditions: -20 ~ 8 ° C

    Grade : Parenteral

    arrow
    Nanjing Well Polylactide-co-glycolide (85:15)

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    07

    Nomisma Healthcare

    PLGA-PEG

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    08

    Nomisma Healthcare

    PLGA

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Brand Name : PLGA

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PLGA

    Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth